Pathogenica Achieves CE Marking for HAI BioDetection Kit
August 14, 2013
BOSTON, MA – Pathogenica, Inc. (www.pathogenica.com) announced today that the company has achieved the CE mark under the European Directive on In Vitro Diagnostic Medical Devices for its HAI BioDetection kit that runs on the Ion PGM™ benchtop sequencer. This milestone marks the HAI BioDetection CE-IVD kit as the first sequence-based infectious disease diagnostic kit [...]
SciAps, Inc. Announces the Inspector SCOPE – a Unique Raman Analyzer
August 14, 2013
SciAps, a Woburn, MA based portable analytical instrumentation company, is pleased to announce the Inspector Scope. The Scope integrates our state-of-the art handheld Raman analyzer with a microscope and XYZ stage. The result is the only in-field, at the bench, in-lab Raman analyzer all in one package. With the Scope, zero in on small samples, [...]
Thermo Fisher Scientific Establishes Pesticide Analysis Center of Excellence
August 14, 2013
SAN JOSE, CALIF., – Government and industry laboratories worldwide have a new resource for improving methods for monitoring and measuring pesticides in food and the environment. The new Thermo Fisher Scientific Pesticide Analysis Center of Excellence (COE) recently opened its doors in Runcorn, UK to help users apply the latest technology and expertise to challenging [...]
Phenomenex Expands Online Chiral Resource with Over 1,700 New Applications
August 14, 2013
Torrance, CA – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of over 1,700 new chiral HPLC/SFC applications to its online resource, including more than 400 new SFC (supercritical fluid chromatography) methods. Phenomenex’s extensive chiral application database is unique in the industry, particularly [...]
August 14, 2013
WALTHAM, Mass.-- PerkinElmer, a global leader in human and environmental health and an innovator in the field of prenatal screening for more than thirty years, announced today the first available early onset preeclampsia screening test in the United States. The PreeclampsiaScreen™ | T1 serum screening test enables physicians to more precisely detect asymptomatic patients in [...]
August 14, 2013
INDIANAPOLIS – BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, announced today that the company has initiated the INTEGRITY Study. The 24-month study will analyze human whole blood samples to measure the impact on the long-term integrity of DNA and RNA when various preparation methods, storage temperatures and storage [...]
Trovagene, Inc. Announces Second Quarter 2013 Earnings
August 14, 2013
SAN DIEGO, Aug. -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the three months and the six months ended June 30, 2013. Second Quarter 2013 Financial Results For the three months ended June 30, 2013, Trovagene reported a net loss of $5.3 million, or $0.34 per [...]
BioLife Solutions Expands Strategic Relationship with STEMCELL Technologies Inc.
August 13, 2013
BOTHELL, WA —— BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, andcontract aseptic media manufacturer, today announced an expansion of its relationship with Vancouver, BC-based STEMCELL Technologies Inc. Since August 2009, STEMCELL Technologies has distributed BioLife’s best in [...]
High-Fidelity PCR Reagents Continue to Propel DNA Research with Unparalleled Accuracy and Speed
August 13, 2013
LAFAYETTE, Colo.-- New proprietary tracking dyes within high-fidelity DNA polymerase and qPCR master mixes facilitate easier, more accurate PCR set-up for researchers. The Thermo Scientific Phusion Green High-Fidelity DNA Polymerase and Luminaris Color qPCR master mixesutilize proprietary tracking dyes to speed up the pipetting process. By providing a visual confirmation, the mixes are designed to [...]
CombiMatrix and Manhattan Labs Enter Strategic Partnership to Service NYC Metropolitan Area
August 13, 2013
IRVINE, Calif., and NEW YORK, -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, and Manhattan Labs jointly announced today that they have entered into a strategic partnership under which Manhattan Labs will market and distribute CombiMatrix microarray tests for the miscarriage management testing market [...]

